View Item 

Show simple item record

Transport of Peptidomimetic Renin Inhibitors Across Monolayers of a Human Intestinal Cell Line (Caco-2): Evidence for Self-Enhancement of Paracellular Transport Route

dc.contributor.authorWalter, Elkeen_US
dc.contributor.authorRaddatz, Peteren_US
dc.contributor.authorKissel, Thomasen_US
dc.date.accessioned2006-09-08T19:15:40Z
dc.date.available2006-09-08T19:15:40Z
dc.date.issued1995-11en_US
dc.identifier.citationWalter, Elke; Kissel, Thomas; Raddatz, Peter; (1995). "Transport of Peptidomimetic Renin Inhibitors Across Monolayers of a Human Intestinal Cell Line (Caco-2): Evidence for Self-Enhancement of Paracellular Transport Route." Pharmaceutical Research 12(11): 1801-1805. <http://hdl.handle.net/2027.42/41441>en_US
dc.identifier.issn0724-8741en_US
dc.identifier.issn1573-904Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/41441
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8592690&dopt=citationen_US
dc.format.extent707519 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherBiomedical Engineeringen_US
dc.subject.otherPermeabilityen_US
dc.subject.otherPeptide Transporten_US
dc.subject.otherRenin Inhibitorsen_US
dc.subject.otherMedical Lawen_US
dc.subject.otherCaco-2en_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherPharmacyen_US
dc.subject.otherCell Cultureen_US
dc.titleTransport of Peptidomimetic Renin Inhibitors Across Monolayers of a Human Intestinal Cell Line (Caco-2): Evidence for Self-Enhancement of Paracellular Transport Routeen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumCollege of Pharmacy, The University of Michigan, Ann Arbor, Michigan, 48109-1065en_US
dc.contributor.affiliationotherE. Merck Darmstadt, Preclinical Pharmaceutical Research, D-64293, Darmstadt, Germanyen_US
dc.contributor.affiliationotherDepartment of Pharmaceutics and Biopharmacy, University of Marburg, Ketzerbach 63, D-35032, Marburg, Germanyen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid8592690en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/41441/1/11095_2004_Article_307075.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1023/A:1016246629130en_US
dc.identifier.sourcePharmaceutical Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
11095_2004_Article_307075.pdf
Size:
690.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.